Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
Clinical trial NCT04339712 · COMPLETED
Trial details
- NCT number
- NCT04339712
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2020-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.